In March 2010, the United States Food and Drug Administration (FDA) announced its intention to rely more heavily on the "responsible corporate officer" (RCO) doctrine to prosecute individuals for violations of the federal Food, Drug and Cosmetic Act (FDCA).
Register Now As you are not an existing subscriber please register for your free daily legal newsfeed service.Register
If you have any questions about the service please contact email@example.com or call Lexology Customer Services on +44 20 7234 0606.
Canada's version of the responsible corporate officer doctrine: can officers be held responsible for pharma violations?
To view this article you need a PDF viewer such as Adobe Reader.
If you are interested in submitting an article to Lexology, please contact Andrew Teague at firstname.lastname@example.org.
PHD, a division of The Fuel Logistics Group (Pty) Ltd